Adcetris Approved for Pediatric Patients With High-Risk Classical Hodgkin Lymphoma
The approval was based on data from the open-label phase 3 AHOD1331 trial.
Diagnosis & Disease Information
Libtayo Plus Chemotherapy Approved as First-Line Treatment for Advanced NSCLC
Findings showed that treatment with cemiplimab-rwlc plus platinum-based chemotherapy demonstrated a statistically significant improvement in overall survival.
FDA Panel Votes Against Omburtamab Due to Multiple Efficacy Issues
Omburtamab is an investigational radiolabeled monoclonal antibody designed to target tumor cells that express B7-H3.
Sapanisertib Fast Tracked for NRF2-Mutated Squamous NSCLC
Sapanisertib is a dual mTORC 1/2 inhibitor that targets a key survival mechanism in KEAP1/NRF2-mutated tumor cells.
Rolvedon Now Available for Chemotherapy-Induced Neutropenia
Rolvedon is a long-acting granulocyte colony-stimulating factor.
Enlarging Breast Mass in 69-Year-Old Woman With History of Cysts
The patient first noticed a firm, nontender, moveable hard mass while conducting a routine breast self-examination in the shower.
Lytgobi Gets Accelerated Approval for Intrahepatic Cholangiocarcinoma
The approval was based on data from the open-label, single-arm phase 2b TAS-120-101 trial.
Bevacizumab Biosimilar Vegzelma Gets FDA Approval
Vegzelma is a vascular endothelial growth factor inhibitor.
Pedmark Approved for Pediatric Cisplatin-Associated Ototoxicity
The approval was based on data from 2 pivotal phase 3 trials, which evaluated Pedmark in pediatric patients undergoing treatment with cisplatin-based chemotherapy.
Use of Geriatric Screening Tools to Assess Older Patients With Cancer
A review of geriatric assessment tools and their role in assessing older patients with cancer before and after treatment.
- Loading...
Loading...
Loading... 
Loading...